Jia Liu

发表

Recent advances in exosome-mediated nucleic acid delivery for cancer therapy

Chengbin Yang, Yujuan Chai, Haoqiang Huang, 2022, Journal of Nanobiotechnology.

Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics

P. Khong, Xiaoyuan Chen, Zhide Guo, 2022, Theranostics.

Mesoporous silica-coated silver nanoparticles as ciprofloxacin/siRNA carriers for accelerated infected wound healing

Xiang Li, Chengbin Yang, Jinbo Lin, 2022, Journal of Nanobiotechnology.

Synergism of 64Cu-Labeled RGD with Anti-PD-L1 Immunotherapy for the Long-Acting Antitumor Effect.

Zhide Guo, Xianzhong Zhang, Xiaoyu Chen, 2022, Bioconjugate chemistry.

PD-L1-Targeted Radionuclide Therapy Combined with αPD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor Effect.

Zhide Guo, Xianzhong Zhang, Yesen Li, 2022, Molecular pharmaceutics.

Synthesis and Preclinical Evaluation of a 68Ga-Labeled Pyridine-Based Benzamide Dimer for Malignant Melanoma Imaging.

Zhide Guo, Xianzhong Zhang, Rongqiang Zhuang, 2022, Molecular pharmaceutics.

Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression

Zijian Zhou, Zhide Guo, Xianzhong Zhang, 2023, European Journal of Nuclear Medicine and Molecular Imaging.

Biodegradable Carbon Dioxide‐Derived Non‐Viral Gene Vectors for Osteosarcoma Gene Therapy

B. Ko, Chengbin Yang, Haoming Lin, 2022, Advanced healthcare materials.

Development of 18F-Labeled Acridone Analogue for Tumor Imaging via Stimulator of Interferon Genes Targeting.

Zhide Guo, Xianzhong Zhang, Yuan Sun, 2023, Molecular pharmaceutics.

Development of STING probes and visualization of STING in multiple tumor types.

Zhide Guo, Gang Liu, Rongqiang Zhuang, 2024, European journal of nuclear medicine and molecular imaging.